Nature Review: AI in drug discovery shows limited clinical impact, calls for focus on decision-making
Sufficient_Okra_2919 · reddit · 2026-08-08
A Perspective in Nature Reviews Drug Discovery critically reviews AI in drug discovery, noting limited clinically relevant impact despite many methods. Reasons include insufficient focus on clinical translation, conditional data, and underspecification. Recommendations include benchmarking for decision improvement.
Related event: Nature Review: AI Drug Discovery Lacks Clinical Impact(2 posts)→
More from Research
- AI will be superhuman at science regardless, and Europe can't opt out — teortaxesTex · 2026-10-16
- SERO augments long-horizon agentic RL with executable oracle continuations — Shanghai-AI-Laboratory · 2026-10-16
- Tsinghua and Amap propose OmniVerifier-C1, a graded verifier beating binary judges — Bowei Liu · 2026-10-16
- Alibaba open-sources MAI-Gym, an all-in-one GUI agent eval and RL training platform — Tongyi-MAI · 2026-10-16
- Peking University's SimForcing distills simulation motion priors into robot world models — PekingUniversity · 2026-10-16
- CoWorld Reasoner uses an evolving video world model as a visual reasoning engine — ModalityDance · 2026-10-16